Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aristo Bio-Tech and Lifescience's interest expense for the
six
months ended in Mar. 2025 was ₹ -10 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-20 Mil.
Aristo Bio-Tech and Lifescience (NSE:ARISTO) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Aristo Bio-Tech and Lifescience's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as
Aristo Bio-Tech and Lifescience did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Aristo Bio-Tech and Lifescience Interest Expense Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aristo Bio-Tech and Lifescience Interest Expense Chart
Aristo Bio-Tech and Lifescience Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a Interest Expense of ₹-20 Mil as of Mar. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Aristo Bio-Tech and Lifescience and its competitors.
Is Aristo Bio-Tech and Lifescience's Interest Expense too high?
Aristo Bio-Tech and Lifescience's current Interest Expense is ₹-20 Mil. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's Interest Expense compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's Interest Expense of ₹-20 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for an Agriculture company?
A good Interest Expense depends on the Agriculture industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Aristo Bio-Tech and Lifescience and its competitors. Aristo Bio-Tech and Lifescience's current Interest Expense is ₹-20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current Interest Expense of ₹-20 Mil. The current Interest Expense is ₹-20 Mil. Aristo Bio-Tech and Lifescience's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current Interest Expense is ₹-20 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aristo Bio-Tech and Lifescience Business Description
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
59GF Score
Get the complete analysis for NSE:ARISTO
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ARISTO has been successfully added to your 
